Cargando…

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy

OBJECTIVES: This longitudinal study compared emerging plasma biomarkers for neurodegenerative disease between controls, patients with Alzheimer’s disease (AD), Lewy body dementia (LBD), frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP). METHODS: Plasma phosphorylated tau at thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chouliaras, Leonidas, Thomas, Alan, Malpetti, Maura, Donaghy, Paul, Kane, Joseph, Mak, Elijah, Savulich, George, Prats-Sedano, Maria A, Heslegrave, Amanda J, Zetterberg, Henrik, Su, Li, Rowe, James Benedict, O'Brien, John Tiernan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Neurodegeneration
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148982/ https://www.ncbi.nlm.nih.gov/pubmed/35078917 http://dx.doi.org/10.1136/jnnp-2021-327788

Ejemplares similares

In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
por: Malpetti, Maura, et al.
Publicado: (2021)

Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
por: Panman, Jessica L, et al.
Publicado: (2021)

Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
por: Saxon, Jennifer A, et al.
Publicado: (2020)

Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort
por: Peakman, Georgia, et al.
Publicado: (2022)

Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
por: van der Ende, Emma L, et al.
Publicado: (2020)

Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Wilson, Katherine M, et al.
Publicado: (2022)

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
por: Berge, Guro, et al.
Publicado: (2014)

Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis
por: Kmetzsch, Virgilio, et al.
Publicado: (2021)

Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia
por: Graham, Neil SN, et al.
Publicado: (2019)

Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes
por: Murley, Alexander G, et al.
Publicado: (2021)

An algorithmic approach to structural imaging in dementia
por: Harper, Lorna, et al.
Publicado: (2014)

Flavour identification in frontotemporal lobar degeneration
por: Omar, Rohani, et al.
Publicado: (2013)

Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis
por: Harper, Lorna, et al.
Publicado: (2017)

The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease
por: Prats‐Sedano, Maria Angeles, et al.
Publicado: (2020)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
por: Thompson, Andrew Geoffrey Bourne, et al.
Publicado: (2018)

Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis
por: Craig, Louise, et al.
Publicado: (2022)

Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer’s Disease and Frontotemporal Dementia
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Peer support and reminiscence therapy for people with dementia and their family carers: a factorial pragmatic randomised trial
por: Charlesworth, Georgina, et al.
Publicado: (2016)

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)

Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
por: Asken, Breton M, et al.
Publicado: (2023)

Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy()
por: Hughes, Laura E., et al.
Publicado: (2013)

Middle-age dementia risk scores and old-age cognition: a quasi-experimental population-based twin study with over 20-year follow-up
por: Iso-Markku, Paula, et al.
Publicado: (2021)

Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia
por: Bocchetta, Martina, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography
por: Mak, Elijah, et al.
Publicado: (2021)

Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage
por: Low, Audrey, et al.
Publicado: (2020)

Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
por: Maccecchini, Maria L, et al.
Publicado: (2012)

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration
por: Alexander, S K, et al.
Publicado: (2014)

Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia
por: Malpetti, Maura, et al.
Publicado: (2023)

Genetic screening in sporadic ALS and FTD
por: Turner, Martin R, et al.
Publicado: (2017)

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
por: David, Michael C B, et al.
Publicado: (2022)

Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic
por: Altomare, Daniele, et al.
Publicado: (2023)

[(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
por: Bevan-Jones, W R, et al.
Publicado: (2018)

Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats
por: Chio, Adriano, et al.
Publicado: (2022)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
por: Maclin, Joshua Marvin Anthony, et al.
Publicado: (2019)

(11)C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_em3gtf0gd1u1ogu6uog8kn09e7